OPEN END TURBO LONG - SMITH & NEPHEW | Real-time Bid/Ask 11:19:07 2024-05-23 am EDT | ||
| 0.96 EUR / 0.98 EUR | -22.40% |
|
| Current month | +48.81% | ||
| 1 month | +26.26% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.94 | -24.80% |
| 24-05-22 | 1.25 | -2.34% |
| 24-05-21 | 1.28 | -10.49% |
| 24-05-20 | 1.43 | +0.70% |
| 24-05-17 | 1.42 | +7.58% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 10:09 am EDT
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG2HRZ |
| ISIN | DE000MG2HRZ9 |
| Date issued | 2024-04-17 |
| Strike | 909.2 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 0.64 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.45 € |
|---|---|
| Lowest since issue | 0.64 € |
| Spread | 0.02 € |
| Spread % | 2.06% |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92
USD
Average target price
16.31
USD
Spread / Average Target
+26.28%
- Stock Market
- Certificates
- Certificat
